Fifth Third Bancorp increased its stake in Dexcom by 206.0% in Q1, requiring SEC disclosure.
1 report, 1 independent
Updated Jul 18
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Fifth Third Bancorp increased its stake in Dexcom by 206.0% in Q1, requiring SEC disclosure.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Fifth Third Bancorp
American bank holding company
-
Dexcom
company that develops, manufactures and distributes continuous glucose monitoring systems
Related events
- Dexcom stock received a raised price objective and rating restatement from analysts, accompanied by SEC filings.
- Fifth Third Bancorp filed institutional investment disclosures regarding an increased stake in Phillips 66 during Q1.
- Fifth Third Bancorp filed its required 13F filings with the Securities and Exchange Commission.
- Norges Bank bought a new stake in Dexcom and Geode Capital Management increased its stake on August 30, 2026.
- Filing disclosures regarding institutional investment activity involving Fifth Third Bancorp, Morgan Stanley, and the Securities and Exchange Commission.